Actelion
Actelion is a bio-technology firm that discovers, develops and commercializes drugs for unmet medical needs.
Business Model:
Revenue: $2.4B
Employees: 1,001-5,000
Rankings
Industries / Tags:
Detailed Actelion Information
Actelion was acquired by
Johnson &a; Johnson.
The acquisition happend on 2017-01-26.
Details of the transaction were not public
Acquirer
Geographic Data
Address: Gewerbestrasse 16
City: Allschwil
State: basel-country
Zip: 4123
Country: CH
Financial Info
Stage:
series unknown
Raised Last:
$12M
Raised Total:$12M
Social
Metrics
8,392,112Website Global Rank
481Website Monthly Traffic
Twitter Followers
Description
Actelion is a bio-technology firm that discovers, develops and commercializes drugs for unmet medical needs.
Contact Phone:
Contact Email:
Actelion went public on 3/14/2003 on the SIX Swiss Exchange
Listed Exchange:
SIX Swiss Exchange
IPO Date:
3/14/2003
Ticker Symbol:
ATLN
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/1998 | Venture Round | 4 | $12M |
Sofinnova Investments Reference Capital SA Atlas Venture HealthCap Sofinnova Investments Reference Capital SA Atlas Venture HealthCap |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 7/2013 | Ceptaris Therapeutics | |
| 7/2010 | Trophos | |
| 11/2006 | Cotherix | |
| 10/2003 | Axovan |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
